NCT04242199 2025-07-14Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid TumorsIncyte CorporationPhase 1 Completed182 enrolled
NCT03674567 2025-01-24Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with PembrolizumabRAPT Therapeutics, Inc.Phase 1/2 Completed323 enrolled